SAG and colorectal adenocarcinoma: As part of this approach, we selected the Oncology VascHT29 Combo ELECT system, which includes HT-29 colorectal adenocarcinoma cells and venular endothelial cells stimulated for 48 hours via the T-cell receptor Sag, along with PBMCs.